ADVERTISEMENT
Pharmacists talking and smiling

Pharmacy-Based Medication Administration Services

The Pharmacy-Based Medication Administration Services Advanced Training Program is a live training program designed to provide learners with an overview of disease states where the use of long-acting injectables have a place in therapy such as HIV, OUD, and behavioral health. Additionally, the program covers proper administration techniques for the safe and effective delivery of long-acting injectables, and considerations related to adverse drug reactions. The program finishes with an assessment of injection technique for intramuscular, subcutaneous, and ventrogluteal injections.

Pricing

If your company or organization is interested in offering this program to your pharmacists and student pharmacists, please contact Chris McKerrow.


Learning objectives and module details
Module 1.1: Delivery Overview

At the completion of this Knowledge-Based activity, participants will be able to:

  • Describe opportunities for pharmacists to provide medication administration services (MAS).
  • Recall how to apply the Pharmacists’ Patient Care Process to the delivery of long-acting injectable (LAI) MAS.
  • Identify strategies for providing MAS in a community pharmacy.
Module 1.2: Use of the Intramuscular Route

At the completion of this Knowledge-Based activity, participants will be able to:

  • Explain why the intramuscular (I.M.) route of delivery is most appropriate for certain medications and describe strategies to minimize risk.
  • List the steps for preparing and administering an I.M. injection.
  • Describe how and when to use the Z-track method for I.M. injections.
Module 1.3: Injection Sites and Injection Administration

At the completion of this Knowledge-Based activity, participants will be able to:

  • List the four sites for I.M. injections.
  • Identify key anatomical surface landmarks and describe underlying tissues for deltoid and ventrogluteal injections.
  • Explain appropriate administration techniques for subcutaneous, deltoid, and ventrogluteal injections.
Module 2: Substance Use Disorder

At the completion of this Knowledge-Based activity, participants will be able to:

  • Examine statistics and relevant public health trends related to OUD.
  • Describe the pharmacology and evidence related to the use of LAI buprenorphine in patients with OUD.
  • Discuss potential adverse reactions related to use of LAI buprenorphine and their management.
  • Identify best practices in communicating with patients with OUD to avoid stigma.
Module 3: HIV Treatment and Prevention

At the completion of this Knowledge-Based activity, participants will be able to:

  • Examine statistics and relevant public health trends related to HIV treatment and prevention.
  • Describe the pharmacology and evidence related to the use of LAI cabotegravir-rilpivirine, cabotegravir and lenacapavir.
  • Discuss potential adverse reactions related to use of LAI cabotegravir- rilpivirine, cabotegravir and lenacapavir.
  • Outline necessary components related to initiation, administration and referral of patients seeking pre-exposure or post-exposure prophylaxis.
  • Identify best practices in communicating with patients with HIV or seeking HIV prevention services to avoid stigma.
Module 4: Schizophrenia and Bipolar Disorder

At the completion of this Knowledge-Based activity, participants will be able to:

  • Examine statistics and relevant public health trends related to schizophrenia and bipolar disorder.
  • Describe the pharmacology and evidence related to the use of first- and second-generation long- acting injectables for management of schizophrenia and bipolar disorder.
  • Discuss potential adverse reactions related to use of first- and second-generation long-acting injectables for management of schizophrenia and bipolar disorder.
  • Identify best practices in communicating and documenting with providers of and patients with schizophrenia or bipolar disorder.
Skills Assessment Component

At the completion of this Application-Based activity, participants will be able to:

  • Demonstrate how to administer a deltoid I.M. injection using the Z-track technique.
  • Demonstrate how to administer a subcutaneous injection.
  • Demonstrate how to administer a ventrogluteal I.M. injection.

How to obtain a certificate of completion
  • Complete the self-study interactive eLearning modules, assessments and videos.
  • Complete the live seminar training and assessment.
  • Achieve a passing grade of 70% or higher on the self-study assessment and final assessment.
    • Credit must be claimed for each module in order to obtain credit.
    • Participants will need to have a valid APhA (pharmacist.com) username and password, as well as a CPE Monitor account to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
    • The certificate of completion will be available online upon successful completion of all course activities on the participant’s My Training page.
    • APhA continuing pharmacy education policy provides you with two opportunities to successfully complete a continuing pharmacy education assessment. Please note that you will not be permitted to submit an assessment a third time. The current policy of the APhA Education Department is not to release the correct answers to any of our CPE tests. This is intended to maintain the integrity of the CPE activity and the assessment.

Accreditation information

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. APhA's Pharmacy-Based Medication Administration Services Advanced Training is approved for a total of 5.25 contact hours of continuing pharmacy education (CPE) credit (0.525 CEUs). The ACPE Universal Activity Numbers (UAN) for this activity are listed below.

  • Pharmacy-Based Medication Administration Services Advanced Training Home Study is approved for 4.25 hours (0.4 CEU) of CPE credit. ACPE UAN 0202-0000-25-290-H01-P
  • Pharmacy-Based Medication Administration Services Skills Assessment is approved for 1 hour (0.1 CEU) of CPE credit. ACPE UAN 0202-0000-26-291-L01-P / 0202-9999-26-291-L01-P
  • Target audience: Pharmacists and student pharmacists
  • Release date: December 12, 2025
  • Expiration date: December 12, 2028 - PLEASE NOTE: NO Home Study credit granted after this date; Live Credit can only be granted within 60 days from the day of the seminar attended or before the expiration date, whichever is sooner.

Technology requirements and tips

Computer and internet access are required to complete this activity. If you experience technical difficulties, try a different web browser.

Please be aware that if the system detects no activity for an extended amount of time while the screen is open in the interactive activity, the Next button may freeze, and you will need to Restart that activity again.

The recommendation is that if you cannot complete the activity within one sitting and need to step away, close the activity so that your place is bookmarked.

If you continue to experience difficulties, please reach out to education@aphanet.org with the name of course, detail of your experience, which web browser(s) used and if possible, screenshots.


Faculty

APhA would like to acknowledge the support and efforts by the following individuals who were responsible for the original Preceptor Central and APhA Advanced Preceptor Training content in 2015.

Contributors

Course authors
Jennifer Cocohoba, PharmD, MAS

Professor of Clinical Pharmacy
University of California, San Francisco
San Francisco, CA

Disclosures: Institution research grant, ViiV Healthcare; Contract (Industry Fellowship), Genentech, Inc.

Katie Meyer, PharmD, BCPS, BCGP

Vice President, Education
American Pharmacists Association
Washington, DC

Disclosure: Nothing to disclose

Hailey Mook, PharmD

Senior Manager, Custom Education
American Pharmacists Association
Washington, DC

Disclosure: Nothing to disclose

Development

Pharmacy-Based Medication Administration Services was developed by the American Pharmacists Association. Copyright © 2025 by the American Pharmacists Association.
All individuals involved in the development of this material declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete APhA staff disclosures, please see the Education and Accreditation Information section at APhA Staff Disclosures.
ADVERTISEMENT